Patients with mild acute ischaemic stroke (AIS) and a favourable risk profile can be treated with low-dose alteplase, Australian researchers say. A study led by the George Institute for Global Health used data from the international ENCHANTED study and a validation cohort from a South Korean stroke registry. The ENCHANTED data showed patients receiving the ...
Already a member?
Enter your email to keep reading.